selected publications
-
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
Thyroid : official journal of the American Thyroid Association.
2022
Academic Article
GET IT
Times cited: 27 -
ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.
AJNR. American journal of neuroradiology.
2022
Academic Article
GET IT
Times cited: 4 - Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients. Neuro-oncology. 2022 Academic Article GET IT
- Semisupervised Training of a Brain MRI Tumor Detection Model Using Mined Annotations. Radiology. 2022 Academic Article GET IT
- Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning. BJR open. 2020 Information Resource GET IT
-
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
The Journal of clinical investigation.
2020
Academic Article
GET IT
Times cited: 145 - Reliability of CT myelography versus MRI in the assessment of spinal epidural disease. Clinical imaging. 2020 Academic Article GET IT
-
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.
International journal of radiation oncology, biology, physics.
2019
Academic Article
GET IT
Times cited: 13 - Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy. Journal of neuro-oncology. 2019 Article GET IT
-
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.
Cancer.
2019
Academic Article
GET IT
Times cited: 6 -
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
The Lancet. Oncology.
2019
Academic Article
GET IT
Times cited: 295 -
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
The Journal of clinical endocrinology and metabolism.
2019
Academic Article
GET IT
Times cited: 147 -
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2019
Academic Article
GET IT
Times cited: 128 -
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
The Lancet. Oncology.
2018
Academic Article
GET IT
Times cited: 184 -
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Annals of oncology : official journal of the European Society for Medical Oncology.
2017
Academic Article
GET IT
Times cited: 33 -
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.
Head & neck.
2017
Academic Article
GET IT
Times cited: 29 -
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.
Pediatric blood & cancer.
2017
Academic Article
GET IT
Times cited: 45 -
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
Breast cancer research : BCR.
2017
Academic Article
GET IT
Times cited: 45 -
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
Cancer.
2017
Academic Article
GET IT
Times cited: 53 -
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
PloS one.
2017
Academic Article
GET IT
Times cited: 32 -
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
Pediatric blood & cancer.
2016
Academic Article
GET IT
Times cited: 34 -
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology.
2016
Academic Article
GET IT
Times cited: 77 -
A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.
Journal of neurosurgery. Pediatrics.
2016
Academic Article
GET IT
Times cited: 12 -
Second-opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care.
Cancer.
2016
Academic Article
GET IT
Times cited: 40 -
Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.
Journal of child neurology.
2016
Review
GET IT
Times cited: 25 -
A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
AJNR. American journal of neuroradiology.
2016
Academic Article
GET IT
Times cited: 4 - Command hallucinations to harm self in a child with recurrent right temporal astrocytoma: a case report. Psycho-oncology. 2015 Article GET IT
-
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.
Head & neck.
2015
Academic Article
GET IT
Times cited: 29 -
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Investigational new drugs.
2014
Academic Article
GET IT
Times cited: 4 -
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Annals of oncology : official journal of the European Society for Medical Oncology.
2014
Academic Article
GET IT
Times cited: 18 -
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Clinical breast cancer.
2013
Academic Article
GET IT
Times cited: 69 -
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer.
International journal of radiation oncology, biology, physics.
2013
Academic Article
GET IT
Times cited: 47 -
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association.
2013
Academic Article
GET IT
Times cited: 60 -
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
The New England journal of medicine.
2013
Academic Article
GET IT
Times cited: 619 -
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.
Cancer.
2013
Academic Article
GET IT
Times cited: 38 -
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer.
Journal of the National Comprehensive Cancer Network : JNCCN.
2012
Academic Article
GET IT
Times cited: 32 -
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
Cancer chemotherapy and pharmacology.
2012
Academic Article
GET IT
Times cited: 27 -
Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis.
Developmental medicine and child neurology.
2012
Academic Article
GET IT
Times cited: 54 -
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.
Cancer.
2012
Academic Article
GET IT
Times cited: 57 -
Hemangioma of the cavernous sinus in a child.
2011
GET IT
Times cited: 3 -
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors.
Cancer chemotherapy and pharmacology.
2011
Academic Article
GET IT
Times cited: 34 -
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
Anticancer research.
2011
Academic Article
GET IT
Times cited: 75 -
A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.
Cancer.
2010
Academic Article
GET IT
Times cited: 8 -
Imaging of metastatic CNS neuroblastoma.
AJR. American journal of roentgenology.
2010
Academic Article
GET IT
Times cited: 29 -
Imaging of lymphoma of the central nervous system, spine, and orbit.
Radiologic clinics of North America.
2008
Information Resource
GET IT
Times cited: 47 -
Intracranial aneurysms in infants and children.
Pediatric radiology.
1998
Academic Article
GET IT
Times cited: 89